BRCA1 and BRCA2 risk perceptions among African American women at increased risk for hereditary breast-ovarian cancer

Community Genetics

Volumn 11, Issue 4, 2008, Pages 193-200

  Kessler, Lisa ^a   Domchek, Susan ^a,b   Stopfer, Jill ^b   Halbert, Chanita Hughes ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

African American women; BRCA1 2 mutation; Risk perception

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AFRICAN AMERICAN; ARTICLE; BREAST CANCER; CANCER CENTER; CANCER RISK; COMMUNITY CARE; DISEASE ASSOCIATION; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENERAL PRACTICE; GENETIC RISK; HIGH RISK POPULATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; TELEPHONE;

AFRICAN AMERICANS; ATTITUDE TO HEALTH; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; RISK FACTORS;

EID: 42349113487     PISSN: 14222795     EISSN: None     Source Type: Journal    
DOI: 10.1159/000116879     Document Type: Article

References (46)

1. Panguluri RC, Brody LC, Modali R, Utley K, Adams-Campbell L, Day AA, Whitfield-Broome C, Dunston GM: BRCA1 mutations in African Americans. Hum Genet 1999;105:28-31.
2. Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, Gumper KL, Scholl T, Tavtigian FV, Pruss Dr, Critchfield GC: Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 2002;20:1480-1490.
3. Nanda R, Schumm LP, Cummings S, Fackenthal JD, Sveen L, Ademuyiwa F, Cobleigh M, Esserman L, Lindor NM, Neuhausen SL, Olopade OI: Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 2005;294:1925-1933.
4. Botkin JR, Croyle RT, Smith KR, Baty BJ, Lerman C, Goldgar DE, Ward JM, Flick BJ, Nash JE: A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing. J Natl Cancer Inst 1996;88:872-882.
5. Lerman C, Biesecker B, Benkendorf JL, Kerner J, Gomez-Caminero A, Hughes C, Reed MM: Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst 1997;89:148-157.
6. Armstrong K, Micco E, Carney A, Stopfer J, Putt M: Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA 2005;293:1729-1736.
7. Halbert CH, Brewster K, Collier A, Smith C, Kessler L, Weathers B, Stopfer JE, Domchek S, Wileyto EP: Recruiting African American women to participate in hereditary breast cancer research. J Clin Oncol 2005;23:7967-7973.
8. Halbert CH, Kessler L, Stopfer JE, Domchek S, Wileyto EP: Low rates of acceptance of BRCA1 and BRCA2 test results among African American women at increased risk for hereditary breast-ovarian cancer. Genet Med 2006;8:576-582.
9. Hughes C, Peterson SK, Ramirez A, Gallion KJ, McDonald P, Skinner S, Bowen D: Minority recruitment in hereditary breast cancer research. Cancer Epidemiol Biomarkers Prev 2004;13:1146-1155.
10. Kinney AY, Croyle RT, Dudley WN, Bailey CA, Pelias MK, Neuhausen SL: Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: a survey of a large African-American kindred with a BRCA1 mutation. Prev Med 2001;33:543-551.
11. Kessler L, Collier A, Brewster K, Smith C, Weathers B, Wileyto EP, Halbert CH: Attitudes about genetic testing and genetic testing intentions in African American women at increased risk for hereditary breast cancer. Genet Med 2005;7:230-238.
12. McInerney-Leo A, Hadley D, Kase RG, Giambarresi TR, Struewing JR, Biesecker BB: BRCA1/2 testing in hereditary breast and ovarian cancer families III: risk perception and screening. Am J Med Genet 2006;140A:2198-2206.
13. Hughes C, Lerman C, Lustbader E: Ethnic differences in risk perception among women at increased risk for breast cancer. Breast Cancer Res Treat 1996;40:25-35.
14. Salant T, Ganschow PS, Olopade OI, Lauderdale DS: Why take it if you don't have anything? Breast cancer risk perceptions and prevention choices at a public hospital. J Gen Intern Med 2006;21:779-785.
15. Berry DA, Parmigiani G, Sanchez J, Schildkraut J, Winer E: Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 1997;89:227-238.
16. Berry DA, Iversen ES, Jr., Gudbjartsson DF, Hiller EH, Garber JE, Peshkin BN, Lerman C, Watson P, Lynch HT, Hilsenbeck HG, Rubinstein WS, Hughes KS, Parmigiani G: BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 2002;20:2701-2712.
17. Vahteristo P, Eerola H, Tamminen A, Blomqvist C, Nevanlinna H: A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families. Br J Cancer 2001;84:704-708.
18. Anton-Culver H, Ziogas A, Bowen D, Finkelstein D, Griffin C, Hanson J, Isaacs C, Kasten-Sportes C, Mineau G, Nadkarni P, Rimer B, Schildkraut J, Strong L, Weber B, Winn D, Hiatt R, Nayfield S: The cancer genetics network: recruitment results and pilot studies. Community Genet 2003;6:171-177.
19. Schwartz MD, Hughes C, Roth J, Main D, Peshkin BN, Isaacs C, Kavanagh C, Lerman C: Spiritual faith and genetic testing decisions among high-risk breast cancer probands. Cancer Epidemiol Biomarkers Prev 2000;9:381-385.
20. Janz NK, Champion VL, Strecher VJ: The health belief model; in Glanz K, Rimer BK, Lewis FM (eds): Health Behavior and Health Education. Theory, Research, and Practice, ed 3. San Francisco, Jossey-Bass, 2002, pp 45-66.
21. Lipkus IM, Kuchibhatla M, McBride CM, Bosworth HB, Pollak KI, Siegler IC, Rimer BK: Relationships among breast cancer perceived absolute risk, comparative risk, and worries. Cancer Epidemiol Biomarkers Prev 2000;9:973-975.
22. Domchek SM, Eisen A, Calzone K, Stopfer J, Blackwood A, Weber BL: Application of breast cancer risk prediction models in clinical practice. J Clin Oncol 2003;21:593-601.
23. Couch FJ, DeShano ML, Blackwood MA, Calzone K, Stopfer JE, Campeau L, Ganguly A, Rebbeck T, Weber BL: BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 1997;336:1409-1415.
24. Parmigiani G, Berry D, Aguilar O: Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 1998;62:145-158.
25. Lerman C, Trock B, Rimer BK, Jepson C, Brody D, Boyce A: Psychological side effects of breast cancer screening. Health Psychol 1991;10:259-267.
26. Lerman C, Kash K, Stefanek M: Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior. J Natl Cancer Inst Monogr 1994:171-176.
27. Bowen DJ, Alfano CM, McGregor BA, Andersen MR: The relationship between perceived risk, affect, and health behaviors. Cancer Detect Prev 2004;28:409-417.
28. Lerman C, Daly M, Masny A, Balshem A: Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 1994;12:843-850.
29. Kash KM, Holland JC, Halper MS, Miller DG: Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 1992;84:24-30.
30. Audrain-McGovern J, Hughes C, Patterson F: Effecting behavior change: awareness of family history. Am J Prev Med 2003;24:183-189.
31. Lerman C, Lustbader E, Rimer B, Daly M, Miller S, Sands C, Balshem A: Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst 1995;87:286-292.
32. Shih HA, Couch FJ, Nathanson KL, Blackwood MA, Rebbeck TR, Armstrong KA, Calzone K, Stopfer J, Seal S, Stratton MR, Weber BL: BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic. J Clin Oncol 2002;20:994-999.
33. Newman LA: Breast cancer in African-American women. Oncologist 2005;10:1-14.
34. Aziz H, Hussain F, Sohn C, Mediavillo R, Saitta A, Hussain A, Brandys M, Homel P, Rotman M: Early onset of breast carcinoma in African American women with poor prognostic factors. Am J Clin Oncol 1999;22:436-440.
35. Joslyn SA, Foote ML, Nasseri K, Coughlin SS, Howe HL: Racial and ethnic disparities in breast cancer rates by age: NAACCR Breast Cancer Project. Breast Cancer Res Treat 2005;92:97-105.
36. Erblich J, Bovbjerg DH, Valdimarsdottir HB: Looking forward and back: distress among women at familial risk for breast cancer. Ann Behav Med 2000;22:53-59.
37. Katapodi MC, Lee KA, Facione NC, Dodd MJ: Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review. Prev Med 2004;38:388-402.
38. Hughes C, Gomez-Caminero A, Benkendorf J, Kerner J, Isaacs C, Barter J, Lerman C: Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Educ Couns 1997;32:51-62.
39. Donovan KA, Tucker DC: Knowledge about genetic risk for breast cancer and perceptions of genetic testing in a sociodemographically diverse sample. J Behav Med 2000;23:15-36.
40. Schapira MM, Davids SL, McAuliffe TL, Nattinger AB: Agreement between scales in the measurement of breast cancer risk perceptions. Risk Anal 2004;24:665-673.
41. Lipkus IM, Iden D, Terrenoire J, Feaganes JR: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer. Cancer Epidemiol Biomarkers Prev 1999;8:533-539.
42. Lerman C, Hughes C, Benkendorf JL, Biesecker B, Kerner J, Willison J, Eads N, Hadley D, Lynch J: Racial differences in testing motivation and psychological distress following pre-test education for BRCA1 gene testing. Cancer Epidemiol Biomarkers Prev 1999;8:361-367.
43. Halbert CH, Schwartz MD, Wenzel L, Narod S, Peshkin BN, Cella D, Lerman C: Predictors of cognitive appraisals following genetic testing for BRCA1 and BRCA2 mutations. J Behav Med 2004;27:373-392.
44. Lannin DR, Mathews HF, Mitchell J, Swanson MS, Swanson FH, Edwards MS: Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA 1998;279:1801-1807.
45. Thompson HS, Valdimarsdottir HB, Duteau-Buck C, Guevarra J, Bovbjerg DH, Richmond-Avellaneda C, Amarel D, Godfrey D, Brown K, Offit K: Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women. Cancer Epidemiol Biomarkers Prev 2002;11:1579-1585.
46. Brown BA, Long HL, Gould H, Weitz T, Milliken N: A conceptual model for the recruitment of diverse women into research studies. J Womens Health Gend Based Med 2000;9:625-632.